APC and colorectal carcinoma: Non-CRC tumors that express low/undetectable levels of human Rspo3 and are wild type for APC, β-catenin and RNF43 were not sensitive to the combination of anti-Rpso3 plus taxane chemotherapy (extended data Fig. 3).